Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 10/20 | 0.63 |
| ▸ | CDK2 | P24941 | 8/20 | 0.63 |
| ▸ | CDK4 | P11802 | 6/20 | 0.63 |
| ▸ | CCND1 | P24385 | 6/20 | 0.63 |
| ▸ | CCNB2 | O95067 | 3/20 | 0.54 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.54 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | JAK1 | P23458 | 9/20 | 0.53 |
| ▸ | TYK2 | P29597 | 9/20 | 0.53 |
| ▸ | JAK3 | P52333 | 7/20 | 0.53 |
| ▸ | JAK2 | O60674 | 6/20 | 0.53 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.53 |
| ▸ | STK10 | O94804 | 2/20 | 0.53 |
| ▸ | CDK14 | O94921 | 2/20 | 0.53 |
| ▸ | ABL1 | P00519 | 2/20 | 0.53 |
| ▸ | CDK11B | P21127 | 2/20 | 0.53 |
| ▸ | TTK | P33981 | 2/20 | 0.53 |
| ▸ | CLK1 | P49759 | 2/20 | 0.53 |
| ▸ | CLK2 | P49760 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1167921 | 0.85 | CDK1 (0.57) | CDK1CDK2CDK4CCND1CCNB2 | |
| SCHEMBL1167828 | 0.80 | CDK2 (0.46) | CDK1CDK2CDK4CCND1CCNB2 | |
| SCHEMBL1167793 | 0.78 | CDK2 (0.44) | CDK1CDK2CDK4CCND1JAK3 | |
| SCHEMBL1167911 | 0.78 | CDK2 (0.44) | CDK1CDK2CDK4CCND1JAK3 | |
| SCHEMBL1167915 | 0.78 | INSR (0.46) | CDK1CDK2CDK4CCND1JAK1 | |
| SCHEMBL3522558 | 0.77 | CDK1 (1.00) | CDK1CDK2CDK4CCND1CCNB2 | |
| SCHEMBL1167433 | 0.77 | CDK2 (0.47) | CDK1CDK2CDK4CCND1 | |
| SCHEMBL1167407 | 0.77 | CDK2 (0.49) | CDK1CDK2CDK4CCND1JAK3 | |
| SCHEMBL3518107 | 0.75 | CDK2 (0.82) | CDK1CDK2CDK4CCND1CCNB2 | |
| SCHEMBL3835330 | 0.75 | CDK2 (0.73) | CDK1CDK2CDK4CCND1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070213375-A1 | Triazole derivatives useful as Axl inhibitors | RIGEL PHARMACEUTICALS, INC. (US) | 2007-09-13 | — | — | US | claimed |
| US-8389557-B2 | Triazole derivatives useful as Axl inhibitors | RIGEL PHARMACEUTICALS, INC. (US) | 2013-03-05 | — | — | US | disclosed |
| US-20110082131-A1 | TRIAZOLE DERIVATIVES USEFUL AS AXL INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2011-04-07 | — | — | US | disclosed |
| US-7884119-B2 | protein tyrosine kinase receptor inhibitors such as 3-amino -1-(1H-indol-5-yl)carbonyl-5-[4-2-(pyrrolidin-1-yl)ethoxy]phenylamino]-1H-1,2,4-triazole, used for treating diseases and conditions associated with neovascularization and/or cell proliferation | RIGEL PHARMACEUTICALS, INC. (US) | 2011-02-08 | — | — | US | disclosed |
| EP-1922310-A2 | TRIAZOLE DERIVATIVES USEFUL AS AXL INHIBITORS | Rigel Pharmaceuticals, Inc. (US) | 2008-05-21 | — | — | EP | disclosed |
| US-20070213375-A1 | Triazole derivatives useful as Axl inhibitors | RIGEL PHARMACEUTICALS, INC. (US) | 2007-09-13 | — | — | US | disclosed |
| WO-2007030680-A2 | TRIAZOLE DERIVATIVES USEFUL AS AXL INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2007-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110082131-A1 | TRIAZOLE DERIVATIVES USEFUL AS AXL INHIBITORS | AXL, TYRO3, FLT3 | CDK1 202/4885CDK2 176/4885CDK4 220/4885 |
| US-20070213375-A1 | Triazole derivatives useful as Axl inhibitors | AXL, TYRO3, FLT3 | CDK1 307/4885CDK2 206/4885CDK4 474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.